🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering products of uncertain source.

Several experts said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and customer laws, risking fines, prosecution or prison.

Platform Response and Content Removal

Based on TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

After minutes of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Within these groups, messages show dark colored parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant medical dangers”.